Literature DB >> 14565901

Bioterrorism and the nervous system.

M H Han1, J R Zunt.   

Abstract

Recent events of war, terrorist attacks, and mail-borne anthrax exposure have produced increasing awareness of potential bioterrorism attacks in the United States and other parts of the world. Physicians and healthcare personnel play a key role in identifying potential bioterrorist attacks. Early recognition and preparedness for bioterrorism-associated illnesses is especially important for neurologists because most bioterrorism agents can directly or indirectly affect the nervous system. This article reviews the neurologic manifestations, diagnosis, and treatments of syndromes caused by potential bioterrorism agents, as well as the potential side effects of vaccines against some of these agents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14565901     DOI: 10.1007/s11910-003-0050-9

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   6.030


  39 in total

1.  Update: Investigation of bioterrorism-related anthrax, 2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-11-16       Impact factor: 17.586

Review 2.  Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

Authors:  T V Inglesby; D T Dennis; D A Henderson; J G Bartlett; M S Ascher; E Eitzen; A D Fine; A M Friedlander; J Hauer; J F Koerner; M Layton; J McDade; M T Osterholm; T O'Toole; G Parker; T M Perl; P K Russell; M Schoch-Spana; K Tonat
Journal:  JAMA       Date:  2000-05-03       Impact factor: 56.272

3.  Clinical categories of neurobrucellosis. A report on 19 cases.

Authors:  R A Shakir; A S Al-Din; G F Araj; A R Lulu; A R Mousa; M A Saadah
Journal:  Brain       Date:  1987-02       Impact factor: 13.501

Review 4.  Venezuelan equine encephalitis.

Authors:  K M Johnson; D H Martin
Journal:  Adv Vet Sci Comp Med       Date:  1974

5.  Anthrax pneumonia.

Authors:  C C Penn; S A Klotz
Journal:  Semin Respir Infect       Date:  1997-03

Review 6.  Optic neuritis after anthrax vaccination.

Authors:  John B Kerrison; David Lounsbury; Charles E Thirkill; R Gary Lane; Martha P Schatz; Renata M Engler
Journal:  Ophthalmology       Date:  2002-01       Impact factor: 12.079

7.  Plague meningitis--a retrospective analysis of cases reported in the United States, 1970-1979.

Authors:  T M Becker; J D Poland; T J Quan; M E White; J M Mann; A M Barnes
Journal:  West J Med       Date:  1987-11

8.  Clinical features of types A and B food-borne botulism.

Authors:  J M Hughes; J R Blumenthal; M H Merson; G L Lombard; V R Dowell; E J Gangarosa
Journal:  Ann Intern Med       Date:  1981-10       Impact factor: 25.391

9.  A massive outbreak of type E botulism associated with traditional salted fish in Cairo.

Authors:  J T Weber; R G Hibbs; A Darwish; B Mishu; A L Corwin; M Rakha; C L Hatheway; S el Sharkawy; S A el-Rahim; M F al-Hamd
Journal:  J Infect Dis       Date:  1993-02       Impact factor: 5.226

10.  Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.

Authors:  J A Jernigan; D S Stephens; D A Ashford; C Omenaca; M S Topiel; M Galbraith; M Tapper; T L Fisk; S Zaki; T Popovic; R F Meyer; C P Quinn; S A Harper; S K Fridkin; J J Sejvar; C W Shepard; M McConnell; J Guarner; W J Shieh; J M Malecki; J L Gerberding; J M Hughes; B A Perkins
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

View more
  4 in total

1.  Bacillus anthracis lethal toxin alters regulation of visceral sympathetic nerve discharge.

Authors:  A A Garcia; R J Fels; L J Mosher; M J Kenney
Journal:  J Appl Physiol (1985)       Date:  2011-11-23

Review 2.  Treatment of neuroterrorism.

Authors:  Katharina M Busl; Thomas P Bleck
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

3.  Neurological and psychiatric presentations associated with human monkeypox virus infection: A systematic review and meta-analysis.

Authors:  James B Badenoch; Isabella Conti; Emma R Rengasamy; Cameron J Watson; Matthew Butler; Zain Hussain; Ben Carter; Alasdair G Rooney; Michael S Zandi; Glyn Lewis; Anthony S David; Catherine F Houlihan; Ava Easton; Benedict D Michael; Krutika Kuppalli; Timothy R Nicholson; Thomas A Pollak; Jonathan P Rogers
Journal:  EClinicalMedicine       Date:  2022-09-08

4.  Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella.

Authors:  Jerome S Harms; Marina A Durward; Diogo M Magnani; Gary A Splitter
Journal:  J Immune Based Ther Vaccines       Date:  2009-01-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.